{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:24:21Z","timestamp":1783423461477,"version":"3.54.6"},"reference-count":226,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110867","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T19:17:48Z","timestamp":1415906268000},"page":"e110867","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy"],"prefix":"10.1371","volume":"9","author":[{"given":"Gabor","family":"Szalai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinnakorn","family":"Chaiworapongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po Jen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunyoung","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya","family":"Plazyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi L.","family":"Tarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Offer","family":"Erez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Hernandez-Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandor Gabor","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"ref1","first-page":"320","article-title":"Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates","volume":"44","author":"PB Medawar","year":"1953","journal-title":"Symp Soc Exp Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.270.5236.630","article-title":"T cell awareness of paternal alloantigens during pregnancy","volume":"270","author":"A Tafuri","year":"1995","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0143-4004(03)00167-X","article-title":"The immunological paradox of pregnancy: a reappraisal","volume":"25","author":"A Moffett","year":"2004","journal-title":"Placenta"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"VR Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni1317","article-title":"Mother&apos;s little helpers: mechanisms of maternal-fetal tolerance","volume":"7","author":"J Trowsdale","year":"2006","journal-title":"Nat Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-065X.2006.00436.x","article-title":"Stranger in a strange land","volume":"213","author":"JS Hunt","year":"2006","journal-title":"Immunol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/eji.200535428","article-title":"Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface","volume":"36","author":"AC Zenclussen","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm1680","article-title":"A pivotal role for galectin-1 in fetomaternal tolerance","volume":"13","author":"SM Blois","year":"2007","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0897.2007.00510.x","article-title":"Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells","volume":"58","author":"P Terness","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1073\/pnas.0807606105","article-title":"Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance","volume":"105","author":"NG Than","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tem.2010.02.003","article-title":"Immune surveillance of the maternal\/fetal interface: controversies and implications","volume":"21","author":"A Erlebacher","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"G Mor","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05938.x","article-title":"Inflammation and pregnancy: the role of the immune system at the implantation site","volume":"1221","author":"G Mor","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0167-5699(93)90235-D","article-title":"Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?","volume":"14","author":"TG Wegmann","year":"1993","journal-title":"Immunol Today"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1472-6483(12)60110-2","article-title":"Implantation and immunology: maternal inflammatory and immune cellular responses to implantation and trophoblast invasion","volume":"4","author":"R Pijnenborg","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.2174\/138161210793797933","article-title":"Pro-inflammatory cytokines in animal and human gestation","volume":"16","author":"L Paulesu","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref17","first-page":"235","article-title":"Amniotic fluid interleukin-1 in spontaneous labor at term","volume":"35","author":"R Romero","year":"1990","journal-title":"J Reprod Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1210\/jc.2004-2496","article-title":"Identification of 9alpha, 11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues","volume":"90","author":"MD Mitchell","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Haddad R, Tromp G, Kuivaniemi H, Chaiworapongsa T, Kim YM, et al.. (2006) Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 195: : 394 e1\u201324.","DOI":"10.1016\/j.ajog.2005.08.057"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.siny.2006.05.001","article-title":"Inflammation in preterm and term labour and delivery","volume":"11","author":"R Romero","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jri.2008.04.002","article-title":"Inflammatory processes in preterm and term parturition","volume":"79","author":"I Christiaens","year":"2008","journal-title":"J Reprod Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1095\/biolreprod.108.069260","article-title":"Region-specific gene expression profiling: novel evidence for biological heterogeneity of the human amnion","volume":"79","author":"YM Han","year":"2008","journal-title":"Biol Reprod"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3109\/14767050903353216","article-title":"The transcriptome of cervical ripening in human pregnancy before the onset of labor at term: identification of novel molecular functions involved in this process","volume":"22","author":"SS Hassan","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/aji.12074","article-title":"Evidence for a role for the adaptive immune response in human term parturition","volume":"69","author":"N Gomez-Lopez","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"ref25","first-page":"31","article-title":"Human decidua: a source of interleukin-1","volume":"73","author":"R Romero","year":"1989","journal-title":"Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"GP Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1067\/mob.2001.117681","article-title":"Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes","volume":"185","author":"MT Gervasi","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mob.2001.117311","article-title":"Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia","volume":"185","author":"MT Gervasi","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1067\/mob.2001.117682","article-title":"Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection","volume":"185","author":"N Naccasha","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/jmf.11.3.171.175","article-title":"Maternal intravascular inflammation in preterm premature rupture of membranes","volume":"11","author":"MT Gervasi","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/jmf.14.4.241.246","article-title":"Unexplained fetal death is associated with changes in the adaptive limb of the maternal immune response consistent with prior antigenic exposure","volume":"14","author":"S Blackwell","year":"2003","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1515\/JPM.2005.052","article-title":"Unexplained intrauterine fetal death is accompanied by activation of complement","volume":"33","author":"K Richani","year":"2005","journal-title":"J Perinat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2559.2006.02542.x","article-title":"Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Toll-like receptors in epidermal keratinocytes","volume":"49","author":"YM Kim","year":"2006","journal-title":"Histopathology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"R Romero","year":"2006","journal-title":"BJOG"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/GRF.0b013e31811ebef6","article-title":"The fetal inflammatory response syndrome","volume":"50","author":"F Gotsch","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1301\/nr.2007.dec.S194-S202","article-title":"Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury","volume":"65","author":"R Romero","year":"2007","journal-title":"Nutr Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2006-956773","article-title":"The role of inflammation and infection in preterm birth","volume":"25","author":"R Romero","year":"2007","journal-title":"Semin Reprod Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/14767050902853117","article-title":"Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death","volume":"22","author":"O Erez","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/JPM.2009.106","article-title":"Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome","volume":"37","author":"SK Kim","year":"2009","journal-title":"J Perinat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/modpathol.2010.73","article-title":"The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth","volume":"23","author":"CJ Kim","year":"2010","journal-title":"Mod Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0897.2009.00791.x","article-title":"The transcriptome of the fetal inflammatory response syndrome","volume":"63","author":"SA Madsen-Bouterse","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/14767050903216033","article-title":"Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia","volume":"23","author":"G Ogge","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2559.2011.04038.x","article-title":"Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies","volume":"59","author":"J Lee","year":"2011","journal-title":"Histopathology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e16806","DOI":"10.1371\/journal.pone.0016806","article-title":"A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d","volume":"6","author":"J Lee","year":"2011","journal-title":"PLoS ONE"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0897.2011.01066.x","article-title":"Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection","volume":"66","author":"J Lee","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.molimm.2011.04.011","article-title":"Complement activation in animal and human pregnancies as a model for immunological recognition","volume":"48","author":"G Girardi","year":"2011","journal-title":"Mol Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/14767058.2011.599083","article-title":"Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE","volume":"25","author":"R Romero","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1469-7580.2008.00978.x","article-title":"Oxygen, the Janus gas; its effects on human placental development and function","volume":"215","author":"GJ Burton","year":"2009","journal-title":"J Anat"},{"key":"ref49","first-page":"283","article-title":"Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy","volume":"80","author":"F Rodesch","year":"1992","journal-title":"Obstet Gynecol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/humrep\/14.11.2901","article-title":"In-vivo measurement of intrauterine gases and acid-base values early in human pregnancy","volume":"14","author":"E Jauniaux","year":"1999","journal-title":"Hum Reprod"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0002-9440(10)64849-3","article-title":"Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure","volume":"157","author":"E Jauniaux","year":"2000","journal-title":"Am J Pathol"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Jauniaux E, Gulbis B, Burton GJ (2003) The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus\u2014a review. Placenta 24 Suppl A: S86\u201393.","DOI":"10.1053\/plac.2002.0932"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9440(10)63803-5","article-title":"Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies","volume":"162","author":"E Jauniaux","year":"2003","journal-title":"Am J Pathol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"GJ Burton","year":"2009","journal-title":"Placenta"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS (2009) Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30 Suppl A: S43\u201348.","DOI":"10.1016\/j.placenta.2008.11.003"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00467-007-0632-x","article-title":"Cellular oxygen sensing in health and disease","volume":"23","author":"DR Mole","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00109-013-1007-3","article-title":"Inflammation and oxidative stress in angiogenesis and vascular disease","volume":"91","author":"YW Kim","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.coph.2013.04.009","article-title":"Targeting the HIF pathway in inflammation and immunity","volume":"13","author":"CC Scholz","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation","volume":"59","author":"DE Clark","year":"1998","journal-title":"Biol Reprod"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/plac.2000.0588","article-title":"Angiogenesis during implantation, and placental and early embryonic development","volume":"22","author":"DM Sherer","year":"2001","journal-title":"Placenta"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/mrd.10308","article-title":"Expression of vascular endothelial growth factor and its receptors in the rhesus monkey (Macaca mulatta) endometrium and placenta during early pregnancy","volume":"65","author":"H Wang","year":"2003","journal-title":"Mol Reprod Dev"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.placenta.2003.10.004","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation","volume":"25","author":"DS Charnock-Jones","year":"2004","journal-title":"Placenta"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"O Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","article-title":"A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate","volume":"21","author":"R Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"JP Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3109\/14767051003681121","article-title":"An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study","volume":"23","author":"R Romero","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e18041","DOI":"10.1371\/journal.pone.0018041","article-title":"Soluble Flt-1 and PlGF: new markers of early pregnancy loss?","volume":"6","author":"S Muttukrishna","year":"2011","journal-title":"PLoS ONE"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e32509","DOI":"10.1371\/journal.pone.0032509","article-title":"Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss","volume":"7","author":"TJ Kaitu'u-Lino","year":"2012","journal-title":"PLoS ONE"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","article-title":"Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium","volume":"376","author":"GH Fong","year":"1995","journal-title":"Nature"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1247\/csf.26.25","article-title":"Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis","volume":"26","author":"M Shibuya","year":"2001","journal-title":"Cell Struct Funct"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2183\/pjab.87.167","article-title":"Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia","volume":"87","author":"M Shibuya","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/mend.13.4.0265","article-title":"Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity","volume":"13","author":"Y He","year":"1999","journal-title":"Mol Endocrinol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"RL Kendall","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/CIRCRESAHA.108.171504","article-title":"A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia","volume":"102","author":"S Sela","year":"2008","journal-title":"Circ Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","article-title":"Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia","volume":"106","author":"A Reuvekamp","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"ref76","first-page":"353","article-title":"Amniotic fluid\u2014soluble vascular endothelial growth factor receptor-1 in preeclampsia","volume":"95","author":"P Vuorela","year":"2000","journal-title":"Obstet Gynecol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"K Koga","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"SE Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award","volume":"190","author":"T Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"RJ Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"R Thadhani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"A Hertig","year":"2004","journal-title":"Clin Chem"},{"key":"ref83","first-page":"728","article-title":"Recent advances in understanding of preeclampsia","volume":"46","author":"Y Bdolah","year":"2005","journal-title":"Croat Med J"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"E Bujold","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"T Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","article-title":"Preeclampsia: a renal perspective","volume":"67","author":"SA Karumanchi","year":"2005","journal-title":"Kidney Int"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","article-title":"Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia","volume":"46","author":"C Lam","year":"2005","journal-title":"Hypertension"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.grf.0000160313.82606.d7","article-title":"Circulating angiogenic factors in preeclampsia","volume":"48","author":"RJ Levine","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"SE Maynard","year":"2005","journal-title":"Pediatr Res"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"S Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"RJ Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2007.02.013","article-title":"Preeclampsia and the kidney: footprints in the urine","volume":"196","author":"SA Karumanchi","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"176 e1","DOI":"10.1016\/j.ajog.2007.03.036","article-title":"Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia","volume":"197","author":"AC Staff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/ndt\/gfm429","article-title":"Angiogenic factors in preeclampsia: so complex, so simple?","volume":"22","author":"N Berkane","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"239 e1","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"LJ Vatten","year":"2007","journal-title":"J Obstet Gynecol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14767050701832833","article-title":"The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation","volume":"21","author":"T Chaiworapongsa","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14767050701831397","article-title":"Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age","volume":"21","author":"T Chaiworapongsa","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14767050802046069","article-title":"Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2","volume":"21","author":"F Gotsch","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejogrb.2007.09.007","article-title":"Soluble endoglin levels during normotensive and hypertensive pregnancies","volume":"140","author":"A Hertig","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/GCO.0b013e328328cf7d","article-title":"The perinatal implications of angiogenic factors","volume":"21","author":"GC Smith","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jri.2009.08.006","article-title":"Novel approaches for mechanistic understanding and predicting preeclampsia","volume":"83","author":"S Kalkunte","year":"2009","journal-title":"J Reprod Immunol"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiol.00043.2008","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"A Wang","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/uog.7491","article-title":"Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations","volume":"35","author":"T Chaiworapongsa","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"550 e1","DOI":"10.1016\/j.ajog.2010.04.002","article-title":"A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia","volume":"202","author":"T Chaiworapongsa","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/14767050903366119","article-title":"Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice","volume":"23","author":"G Ogge","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"RW Powers","year":"2010","journal-title":"PLoS ONE"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jri.2010.01.002","article-title":"Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia","volume":"85","author":"S Sharma","year":"2010","journal-title":"J Reprod Immunol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"594 e1","DOI":"10.1016\/j.ajog.2010.03.006","article-title":"Soluble endoglin in preeclamptic patients with or without HELLP syndrome","volume":"202","author":"A Hertig","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"T Chaiworapongsa","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"152 e1","DOI":"10.1016\/j.ajog.2010.08.049","article-title":"Circulating angiogenic and antiangiogenic factors in women with eclampsia","volume":"204","author":"E Vaisbuch","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semnephrol.2010.10.004","article-title":"Angiogenic factors and preeclampsia","volume":"31","author":"SE Maynard","year":"2011","journal-title":"Semin Nephrol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/14767058.2012.722725","article-title":"Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia","volume":"26","author":"T Eshkoli","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3109\/14767058.2012.713055","article-title":"Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia","volume":"25","author":"AG Moore","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"S Rana","year":"2012","journal-title":"Circulation"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/14767058.2012.733747","article-title":"Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis","volume":"26","author":"T Reimer","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20110097","article-title":"Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia","volume":"122","author":"S Verlohren","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"140 e1","DOI":"10.1016\/j.ajog.2012.05.003","article-title":"Examining the correlation between placental and serum placenta growth factor in preeclampsia","volume":"207","author":"S Weed","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","article-title":"Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth","volume":"58","author":"J Jebbink","year":"2011","journal-title":"Hypertension"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1471-0528.2011.02962.x","article-title":"Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia","volume":"118","author":"CL Whitehead","year":"2011","journal-title":"BJOG"},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"Szalai G, Roberto R, Chaiworapongsa T, Xu Y, Wang B, et al.. (2014) Full-lenght human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice. submitted.","DOI":"10.1371\/journal.pone.0119547"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"K Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Z Li","year":"2007","journal-title":"Hypertension"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, et al.. (2007) The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 196: : 396 e1\u20137.","DOI":"10.1016\/j.ajog.2006.12.024"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Lu F, Bytautiene E, Tamayo E, Gamble P, Anderson GD, et al.. (2007) Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol 197: : 418 e1\u20135.","DOI":"10.1016\/j.ajog.2007.06.064"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"432 e1","DOI":"10.1016\/j.ajog.2009.01.044","article-title":"The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model","volume":"200","author":"BD Byers","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","article-title":"Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model","volume":"14","author":"A Bergmann","year":"2010","journal-title":"J Cell Mol Med"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.00792.2009","article-title":"Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia","volume":"298","author":"E Bytautiene","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"MM Costantine","year":"2010","journal-title":"Obstet Gynecol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"366 e1","DOI":"10.1016\/j.ajog.2011.06.083","article-title":"Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia","volume":"205","author":"KA Fox","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"H1781","DOI":"10.1152\/ajpheart.00373.2011","article-title":"Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1","volume":"301","author":"J Mateus","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.109.134668","article-title":"Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice","volume":"54","author":"H Suzuki","year":"2009","journal-title":"Hypertension"},{"key":"ref132","unstructured":"National Research Council of the National Academies (2011) Guide for the Care and Use of Laboratory Animals Washington, DC: The National Academies Press."},{"key":"ref133","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.gt.3301453","article-title":"A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob","volume":"8","author":"H Mizuguchi","year":"2001","journal-title":"Gene Ther"},{"key":"ref134","unstructured":"Ahn H, Szalai G, Hernandez-Andrade E, Than NG, King M, et al.. (2014) Ultrasound-guided cystocentesis for obtaining urine samples in pregnant mice. <italic>in preparation<\/italic>."},{"key":"ref135","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/endo-118-4-1567","article-title":"Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae","volume":"118","author":"HJ Kliman","year":"1986","journal-title":"Endocrinology"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"AI Su","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.biomaterials.2011.02.038","article-title":"Enhanced in vivo gene transfer into the placenta using RGD fiber-mutant adenovirus vector","volume":"32","author":"K Katayama","year":"2011","journal-title":"Biomaterials"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1210\/en.2004-1606","article-title":"Genomic regions that mediate placental cell-specific and developmental regulation of human Cyp19 (aromatase) gene expression in transgenic mice","volume":"146","author":"A Kamat","year":"2005","journal-title":"Endocrinology"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.placenta.2003.10.009","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy","volume":"25","author":"P Kaufmann","year":"2004","journal-title":"Placenta"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.placenta.2003.10.010","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies","volume":"25","author":"TM Mayhew","year":"2004","journal-title":"Placenta"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0143-4004(94)90002-7","article-title":"Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation","volume":"15","author":"MR Jackson","year":"1994","journal-title":"Placenta"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-0528.1996.tb09627.x","article-title":"VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia","volume":"103","author":"JC Cooper","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"ref143","first-page":"361","article-title":"Expression of the vascular endothelial growth factor receptor, KDR, in human placenta","volume":"2)","author":"M Vuckovic","year":"1996","journal-title":"J Anat 188 (Pt"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0143-4004(96)80004-X","article-title":"Immunohistochemical localization of vascular endothelial growth factor in the human placenta","volume":"17","author":"S Shiraishi","year":"1996","journal-title":"Placenta"},{"key":"ref145","first-page":"519","article-title":"Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family","volume":"5","author":"M Shibuya","year":"1990","journal-title":"Oncogene"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.placenta.2008.12.010","article-title":"Novel splice variants of sFlt1 are upregulated in preeclampsia","volume":"30","author":"M Heydarian","year":"2009","journal-title":"Placenta"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1096\/fj.07-8809com","article-title":"Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta","volume":"21","author":"CP Thomas","year":"2007","journal-title":"FASEB J"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1210\/jc.2009-0017","article-title":"A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia","volume":"94","author":"CP Thomas","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/jrf.0.0990609","article-title":"Expression of mRNA for vascular endothelial growth factor in human placenta","volume":"99","author":"AM Sharkey","year":"1993","journal-title":"J Reprod Fertil"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08977199509036883","article-title":"Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta","volume":"12","author":"A Ahmed","year":"1995","journal-title":"Growth Factors"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0143-4004(95)90115-9","article-title":"Angiogenesis and the placental environment","volume":"16","author":"T Wheeler","year":"1995","journal-title":"Placenta"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0143-4004(97)90007-2","article-title":"Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast","volume":"18","author":"VH Shore","year":"1997","journal-title":"Placenta"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/dbio.1996.9993","article-title":"VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane","volume":"176","author":"J Wilting","year":"1996","journal-title":"Dev Biol"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"S De Falco","year":"2012","journal-title":"Exp Mol Med"},{"key":"ref155","doi-asserted-by":"crossref","unstructured":"Fan X, Rai A, Kambham N, Sung JF, Singh N, et al.. (2014) Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest doi: 10.1172\/JCI76864.","DOI":"10.1172\/JCI76864"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1006\/bbrc.2002.6478","article-title":"Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians","volume":"291","author":"S Yamaguchi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/35080570","article-title":"Placental development: lessons from mouse mutants","volume":"2","author":"J Rossant","year":"2001","journal-title":"Nat Rev Genet"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/dbio.2002.0773","article-title":"Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta","volume":"250","author":"SL Adamson","year":"2002","journal-title":"Dev Biol"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/plac.2001.0738","article-title":"Comparative developmental anatomy of the murine and human definitive placentae","volume":"23","author":"P Georgiades","year":"2002","journal-title":"Placenta"},{"key":"ref160","doi-asserted-by":"crossref","unstructured":"Carter AM (2007) Animal models of human placentation\u2014a review. Placenta 28 Suppl A: S41\u201347.","DOI":"10.1016\/j.placenta.2006.11.002"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/msb.2009.37","article-title":"Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology","volume":"5","author":"B Cox","year":"2009","journal-title":"Mol Syst Biol"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/path.1700930219","article-title":"The pathological response of the vessels of the placental bed to hypertensive pregnancy","volume":"93","author":"WB Robertson","year":"1967","journal-title":"J Pathol Bacteriol"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0306-3356(21)00411-8","article-title":"Morphological changes in the utero-placental bed in pregnancy hypertension","volume":"4","author":"IA Brosens","year":"1977","journal-title":"Clin Obstet Gynaecol"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-0528.1981.tb02222.x","article-title":"Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation","volume":"88","author":"G Gerretsen","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1471-0528.1986.tb07830.x","article-title":"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants","volume":"93","author":"TY Khong","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Y Zhou","year":"1997","journal-title":"J Clin Invest"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","article-title":"Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia","volume":"69","author":"P Kaufmann","year":"2003","journal-title":"Biol Reprod"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"J Espinoza","year":"2006","journal-title":"J Perinat Med"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/humrep\/dep474","article-title":"The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders?","volume":"25","author":"I Brosens","year":"2010","journal-title":"Hum Reprod"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The &quot;Great Obstetrical Syndromes&quot; are associated with disorders of deep placentation","volume":"204","author":"I Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.placenta.2008.09.003","article-title":"Protein nitration in placenta - functional significance","volume":"29","author":"RP Webster","year":"2008","journal-title":"Placenta"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1538-7836.2008.03259.x","article-title":"Vascular biology of preeclampsia","volume":"7","author":"L Myatt","year":"2009","journal-title":"J Thromb Haemost"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"BC Young","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"ref174","unstructured":"Redman CW, Sargent IL (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response\u2014a review. Placenta 24 Suppl A: S21\u201327."},{"key":"ref175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0378(03)00044-5","article-title":"Trophoblast deportation and the maternal inflammatory response in pre-eclampsia","volume":"59","author":"IL Sargent","year":"2003","journal-title":"J Reprod Immunol"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"CW Redman","year":"2005","journal-title":"Science"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","article-title":"Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles","volume":"178","author":"SJ Germain","year":"2007","journal-title":"J Immunol"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00428-008-0658-x","article-title":"Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome","volume":"453","author":"NG Than","year":"2008","journal-title":"Virchows Arch"},{"key":"ref179","unstructured":"Redman CW, Sargent IL (2009) Placental stress and pre-eclampsia: a revised view. Placenta 30 Suppl A: S38\u201342."},{"key":"ref180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.placenta.2010.10.003","article-title":"Inhibition of HTRA3 stimulates trophoblast invasion during human placental development","volume":"31","author":"H Singh","year":"2010","journal-title":"Placenta"},{"key":"ref181","doi-asserted-by":"crossref","unstructured":"Balogh A, Pozsgay J, Matko J, Dong Z, Kim CJ, et al.. (2011) Placental protein 13 (PP13\/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am J Obstet Gynecol 205: : 156 e1\u201314.","DOI":"10.1016\/j.ajog.2011.03.023"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/jc.2010-1405","article-title":"Placental HtrA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia","volume":"96","author":"Y Li","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"e45956","DOI":"10.1371\/journal.pone.0045956","article-title":"HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening","volume":"7","author":"K Dynon","year":"2012","journal-title":"PLoS ONE"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/plac.2000.0560","article-title":"Placental debris, oxidative stress and pre-eclampsia","volume":"21","author":"CW Redman","year":"2000","journal-title":"Placenta"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1067\/mob.2002.127309","article-title":"Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia","volume":"187","author":"T Chaiworapongsa","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.placenta.2011.12.006","article-title":"Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia","volume":"33","author":"CW Redman","year":"2012","journal-title":"Placenta"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"JM Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9378(93)90154-B","article-title":"Endothelial vasoactive mediators in preeclampsia","volume":"169","author":"AA Kraayenbrink","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0002-9378(98)70380-1","article-title":"Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia","volume":"179","author":"JR Higgins","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"ref190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2007-1016249","article-title":"Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia","volume":"16","author":"RN Taylor","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"CW Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14767050802034859","article-title":"Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation","volume":"21","author":"O Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14767050802361872","article-title":"Tissue factor and its natural inhibitor in pre-eclampsia and SGA","volume":"21","author":"O Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/14767050902801751","article-title":"Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death","volume":"22","author":"O Erez","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref195","unstructured":"Roberts JM, Hubel CA (2009) The two stage model of preeclampsia: variations on the theme. Placenta 30 Suppl A: S32\u201337."},{"key":"ref196","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-0528.1980.tb04419.x","article-title":"Fetal growth retardation and pre-eclampsia","volume":"87","author":"PA Long","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9378(96)70056-X","article-title":"Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications","volume":"175","author":"RB Ness","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"P von Dadelszen","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"B Sibai","year":"2005","journal-title":"Lancet"},{"key":"ref200","doi-asserted-by":"crossref","unstructured":"Than NG, Vaisbuch E, Kim CJ, Mazaki-Tovi S, Erez O, et al.. (2012) Early-Onset Preeclampsia and HELLP Syndrome: An Overview. In: Preedy VR, editor. Handbook of growth and growth monitoring in health and disease. Heidelberg: Springer. pp. 1867\u20131891.","DOI":"10.1007\/978-1-4419-1795-9_113"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"JS Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/014436105400041396","article-title":"Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity","volume":"25","author":"NJ Sebire","year":"2005","journal-title":"J Obstet Gynaecol"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"G Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/aje\/155.3.203","article-title":"Impact of preeclampsia and gestational hypertension on birth weight by gestational age","volume":"155","author":"X Xiong","year":"2002","journal-title":"Am J Epidemiol"},{"key":"ref205","first-page":"575","article-title":"Fetal growth and body proportion in preeclampsia","volume":"101","author":"S Rasmussen","year":"2003","journal-title":"Obstet Gynecol"},{"key":"ref206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","article-title":"A critical review of early-onset and late-onset preeclampsia","volume":"66","author":"D Raymond","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"CW Redman","year":"2014","journal-title":"Placenta"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00006254-194810000-00002","article-title":"Placental dysfunction in eclamptogenic toxemias","volume":"3","author":"EW Page","year":"1948","journal-title":"Obstet Gynecol Surv"},{"key":"ref209","first-page":"1","article-title":"The physiologic basis of symptoms in eclampsia","volume":"70","author":"EW Page","year":"1949","journal-title":"Calif Med"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"CW Redman","year":"1991","journal-title":"Placenta"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ogc.2010.02.013","article-title":"Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia","volume":"37","author":"M Silasi","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"EA Steegers","year":"2010","journal-title":"Lancet"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bpobgyn.2011.01.005","article-title":"The origins and end-organ consequence of pre-eclampsia","volume":"25","author":"G Eastabrook","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref214","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.med.59.110106.214058","article-title":"Preeclampsia and angiogenic imbalance","volume":"59","author":"S Maynard","year":"2008","journal-title":"Annu Rev Med"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","article-title":"Adenoviruses as gene-delivery vehicles","volume":"334","author":"JM Wilson","year":"1996","journal-title":"N Engl J Med"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/10430340050016247","article-title":"Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta","volume":"11","author":"A Xing","year":"2000","journal-title":"Hum Gene Ther"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.placenta.2010.12.017","article-title":"Review: Genetic manipulation of the rodent placenta","volume":"32","author":"SJ Renaud","year":"2011","journal-title":"Placenta"},{"key":"ref218","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0378-1119(98)00006-7","article-title":"Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors","volume":"208","author":"K Kondo","year":"1998","journal-title":"Gene"},{"key":"ref219","doi-asserted-by":"crossref","unstructured":"Katz AB, Keswani SG, Habli M, Lim FY, Zoltick PW, et al.. (2009) Placental gene transfer: transgene screening in mice for trophic effects on the placenta. Am J Obstet Gynecol 201: : 499 e1\u20138.","DOI":"10.1016\/j.ajog.2009.06.029"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"R Thadhani","year":"2011","journal-title":"Circulation"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"HU Irgens","year":"2001","journal-title":"BMJ"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"273 e1","DOI":"10.1016\/j.ajog.2007.05.047","article-title":"Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease?","volume":"197","author":"CV Ananth","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"ref223","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.AOG.0000266983.77458.71","article-title":"Recurrence of ischemic placental disease","volume":"110","author":"CV Ananth","year":"2007","journal-title":"Obstet Gynecol"},{"key":"ref224","doi-asserted-by":"crossref","first-page":"c72","DOI":"10.1159\/000101801","article-title":"Pre-eclampsia: clinical manifestations and molecular mechanisms","volume":"106","author":"S Baumwell","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.maturitas.2010.08.002","article-title":"Preeclampsia as a female-specific risk factor for chronic hypertension","volume":"67","author":"JT Drost","year":"2010","journal-title":"Maturitas"},{"key":"ref226","doi-asserted-by":"crossref","unstructured":"Bytautiene E, Bulayeva N, Bhat G, Li L, Rosenblatt KP, et al.. (2013) Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol 208: : 388 e1\u20138.","DOI":"10.1016\/j.ajog.2013.01.042"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T03:36:58Z","timestamp":1689651418000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110867"}},"subtitle":[],"editor":[{"given":"Sinuhe","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":226,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110867","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}